Request Trial
29 October 2024NewsAmericasWendy Devine, Partner, Wilson Sonsini | Jesse Fecker, Vice President, Head of IP, Theravance Bio | Christina Susanto, Director of IP, Sutro Bipharma | Lawrence Kong, Executive Director, Legal and Intellectual Property, Addition Therapeutics

WATCH: Aligning innovation, regulation and IP protection

Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
5 ways the USPTO director is changing US innovation
24 December 2025   John Squires has rewired the country’s patents system since becoming USPTO director—but which changes are most impactful? Sarah Speight explores.
Americas
Mirum targets generics in quartet of suits over liver treatment
22 December 2025   Biopharma company and two others have taken action against numerous defendants over proposed generic versions of Livmarli, Mirum’s core revenue driver.
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025   The proponents of a petition denied by the Supreme Court said it addressed a conflict that was significant “not just for the pharmaceutical industry, but for all stakeholders in our patent system”.


Editor's picks

SCOTUS shuts the door on Entresto ‘after-arising technology’ review
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025

Editor's picks

Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025
Europe
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
25 November 2025
Americas
INTA votes in new 2026 president at Florida leadership meeting
20 November 2025

More features

Mental health in IP: ‘We have a clear picture of the problem’
From Edwards to Insulet: Three key medical device cases of 2025
Edwards v Meril: Behind the UPC’s landmark medtech showdown
5 ways the USPTO director is changing US innovation
EU unveils sweeping pharma, biotech, and medical device reforms
Mirum targets generics in quartet of suits over liver treatment
Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm
WATCH: Enabling success — overcoming §112 in the new era of life sciences patents